We are pleased to announce that Angiolite DES, offers one of the highest overexpansion capacités pour navires moyens et grands. This excellent feature helps to choose the most suitable stent size, which ensures a correct stent apposition, independently of diameters disparity along the lesions treated.
Angiolite’s overexpansion capacity is 6.00mm for diameters of 4.00 and 4.50. For small vessels, from 2.00 to 2.50, the maximum overexpansion capacity is 4.00mm. Furthermore, for medium vessels, such as 2.75, 3.00 and 3.50, L’angiolite offre un diamètre maximum de post-dilatation de 5,25 mm.
L’objectif d’iVascular avec cette nouvelle fonctionnalité est d’apporter de la valeur à la pratique clinique quotidienne afin d’améliorer les résultats de procédures complexes, en tant que segments principaux gauches et longs bifurqués.
À propos de l’angiolite
Angiolite is a DES, indicated for patients with symptomatic ischemic heart disease due to “de novo” stenotic and re-stenotic lesions and patients with occlusive disease due to acute myocardial infarction. It has been specifically designed, and feature alternating links to achieve a homogeneous arterial coverage with high rates of endothelialization due to its polymère fluoré et TransferWise, proprietary iVascular nanotechnology.
The clinical evidence of Angiolite has been demonstrated in several clinical trials. The most recent being Registre RANGO, which includes high-risk populations. In this registry, Angiolite demonstrates outstanding efficacy and safety profile.
Lear more à propos de l’Angiolite et de ses preuves cliniques.
Remarque : Le texte de cet article a été traduit en français à l’aide de l’intelligence artificielle.
